Umoja Biopharma
Umoja Biopharma focuses on innovative immunotherapy by reprogramming T cells within the patient's body to target cancer effectively. The company offers scalable therapeutic regimens designed for solid tumors and hematological cancers that typically respond poorly to current treatments. Its in-house CAR T-cell gene therapy platform aims to improve patient outcomes across various stages of cancer.
Domain
umoja-biopharma.com
Country
United StatesIndustry
BiopharmaEmployees
101-250
Last Funding
$100.0M
Founded
2018
Tech Stack (16 technologies)
Frequently Asked Questions
What technologies does Umoja Biopharma use?+
Umoja Biopharma uses 16 technologies including Astra, Elementor, Google Analytics.
What industry is Umoja Biopharma in?+
Umoja Biopharma operates in the Biopharma industry.
Where is Umoja Biopharma based?+
Umoja Biopharma is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026